logo
ProjectEnded

Low cost tracking and data management solution for biopharma cold chain logistics

Ended · Denmark

Source: EU Funding & Tenders Portal

The Danish company Globe Tracker International (GT) is revolutionizing supply chain visibility and profitability as a leading provider of data sharing, data analytics and global asset tracking. GT has developed a fully functional hardware/data management system that is ready to be deployed globally and is currently being tested in commercial trials in the reefer market. GT has partnered with globa

Status
Closed
Sector
Hospital, Warehouse, Commercial
Location
Denmark
Updated
22 Jul 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Low cost tracking and data management solution for biopharma cold chain logistics

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Low cost tracking and data management solution for biopharma cold chain logistics” is an infrastructure initiative in the Hospital sector, located in Denmark. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

ended

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

The Danish company Globe Tracker International (GT) is revolutionizing supply chain visibility and profitability as a leading provider of data sharing, data analytics and global asset tracking. GT has developed a fully functional hardware/data management system that is ready to be deployed globally and is currently being tested in commercial trials in the reefer market. GT has partnered with global OEMs, container manufacturers and data transmission companies to help commercial expansion. For this project, GT has identified the the pharma product delivery market as a high value segment in which demand exists but where its solution needs adaptation to meet customer and regulatory requirements. The demand stems from the need for safe, secure and efficient distribution of pharma products in a strictly controlled and refrigerated environment in order to protect the integrity of the drugs. Today temperature deviations endanger patient safety and increase costs. In addition, sabotage and counterfeiting damages safety and brand values. This need is especially apparent in the fast growing biologics market that already represents a third of blockbuster pharma shipments and over half of clinic trials. The feasibility study will (1) identify the most promising pharma market niche for entry that will ultimately open up growth into all other temperature/security/counterfeit relevant segments and (2) define the technical design for its final products to deliver the largest possible economic benefits to the supply chain. The feasibility study will help to understand how the multi-layered stakeholders need to be involved. GT will evaluate the competitive landscape, analyse pricing and ROI models and monitor its FTO position, while it is building a patent portfolio throughout Phase1 and Phase 2. The succesful outcome of the Phase II project will reduce product loss by 25%, reduce the influx of counterfeit by 50% and ensure compliance with recent EU and US logistics regulations.

Location

Country

Denmark

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Hospital, Warehouse, Commercial

Article published date

2026-01-15

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project